AR and prostate carcinoma: Next, to identify kinases of which knock‐down enhanced the docetaxel sensitivity in PCa cells, we conducted a high‐throughput kinome‐wide shRNA screen in the AR‐negative DU145 prostate cancer cells in the presence or absence of a sublethal concentration of docetaxel.